Abstract
The structure-based design, chemical synthesis, and biological evaluation of bicyclic 2-pyridone-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. An optimized compound is shown to exhibit antiviral activity when tested against a variety of HRV serotypes (EC 50's ranging from 0.037 to 0.162 μM).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have